-
October 6, 2021
Formula One Racing and Intellectual Property - Do Auto Racing and IP Mix?
-
September 15, 2021
Juno Therapeutics, INC., Sloan Kettering Institute for Cancer Research v. Kite Pharma, INC.
-
June 9, 2021
Raytheon Technologies Corporation v. General Electric Company (Fed. Cir. 2021)
-
May 26, 2021
Trimble Inc., Innovative Software Engineering, LLC, v. PerDiemCo LLC Case
-
April 21, 2021
A Review of USPTO Pilot Programs and Initiatives
-
March 24, 2021
Recitation of “Module” Renders Claims Indefinite in Rain Computing v. Samsung
-
April 7, 2021
IBSA Institut Biochimique, S.A. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2020)
-
December 9, 2020
Precedential Decisions When Challenging Patents
-
December 2, 2020
ClearCorrect Operating, LLC v. ITC
-
November 18, 2020
USPTO’s recent changes in its revised First Action Final Rejection (FAFR) policy appear navigable to Patent Practitioners
-
September 9, 2020
AI Inventor Debate
-
June 17, 2020
Cardionet, LLC v. Infobionic, Inc, Appeal No. 2019-1149 (Fed. Cir. Decided April 17, 2020) (Precedential)
-
May 20, 2020
The Buck Stops with the PTAB
-
February 27, 2012
Presents at the 3rd China International Pharma, Biotech & Chemical Intellectual Property Forum
-
April 1, 2013
Considerations and Pitfalls for Doing Collaborative R&D
-
January 29, 2014
Two Recent Decisions Involving the Hatch-Waxman Act
-
January 29, 2014
When does Functional Language in an Apparatus Claim become a Claim Limitation? (Nazomi Communications, Inc. v. Western Digital Corp. and Sling Media, Inc.)
-
February 5, 2014
New Global Pilot is Harmonizing the Patent Prosecution Highway
-
February 12, 2014
Inconsistent Statements on Claim Scope during Prosecution can Later Invalidate a Patent as being Indefinite (Teva Pharm. USA, Inc. v. Sandoz, Inc.)
-
February 12, 2014
Recent Board Decisions in Group 2100
